Biotherapeutic approaches to asthma /
Biological response modifiers.
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Dekker,
[2002]
|
| Series: | Lung biology in health and disease ;
167. |
| Subjects: |
Table of Contents:
- Pt. I. Inhibiting allergen sensitization
- Strategies for the primary prevention of asthma
- The role of aeroallergens : what is the case for primary avoidance?
- Pt. II. Inhibiting IgE response
- Anti-IgE and the treatment of asthma and allergic disease
- Pt. III. Inhibition of mast-cell-mediator release or activity
- Counterregulation of cell activation by the immunoreceptor tyrosine-based inhibitory motif
- Protease-activated receptors, tryptases, and mast-cell-mediated immune responses in the lung
- Pt. IV. Targeting proallergic cytokines
- Interleukin-4 inhibition for the treatment of asthma
- Immunobiology of asthma : biotherapeutic management
- Therapeutic targeting of chemokines and chemokine receptors
- IL-13 antagonism as a therapeutic strategy for the treatment of asthma
- Tumor necrosis factor α and interleukin-1beta inhibitory therapies
- Pt. V. Inhibition of the Th2 response
- Development and inhibition of the Th2 responses : realization of therapeutic targets
- Pt. VI. Newer anti-inflammatories
- Cell adhesion molecule blockers and/or modulators : potential therapeutic tools in asthma
- Pt. VII. Role of allergen-specific immunotherapy
- Allergen-specific immunotherapy
- Pt. VIII. Corticosteroid effects
- Glucocorticoid effects on mediator modulation
- Pt. IX. Summary and future directions
- Future therapies for asthma.